Fulcrum Therapeutics, Inc.
Develops small molecule therapies for rare, genetically defined diseases.
FULC | US
Overview
Corporate Details
- ISIN(s):
- US3596161097
- LEI:
- Country:
- United States of America
- Address:
- 26 LANDSDOWNE STREET, 2139 CAMBRIDGE
- Website:
- https://www.fulcrumtx.com/
- Sector:
- Manufacturing
Description
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small molecule therapies for genetically defined diseases with high unmet medical needs. The company utilizes a proprietary technology platform to identify drug targets that can modulate gene expression, aiming to treat the root cause of a disease. This approach focuses on regulating genes that are incorrectly expressed. Fulcrum's pipeline is concentrated on creating disease-modifying treatments for rare conditions, with key programs in sickle cell disease and facioscapulohumeral muscular dystrophy (FSHD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Fulcrum Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fulcrum Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fulcrum Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
